Combining Anti-HER3 Antibody, HMBD-001, with EGFR Inhibition and Chemotherapy may Improve Treatment Outcomes in SqNSCLC-MedSci.cn

Combining Anti-HER3 Antibody, HMBD-001, with EGFR Inhibition and Chemotherapy may Improve Treatment Outcomes in SqNSCLC

Toy, W; Thakkar, D; Luu, K; Bui, NLC; Chau, KF; Lai, J; Ray, D; Wu, S; Poi, M; Gandhi, NA; Mas, A; Paszkiewicz, K; Ingram, P; Boyd-Kirkup, J

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (11): S208

科室
- - 订阅+
  - 更多科室
工具
服务